What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence
Annals of Internal Medicine · 2026-06 · 179 (6) · 895-897
DOI: 10.7326/annals-26-00362 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Internal Medicine, 2026-06. Verfasst von Kyra L Rosen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Computational Health Informatics Program, Boston Children's Hospital, Boston; and Harvard Medical School, Boston, Massachusetts (K.L.R.). Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Computational Health Informatics Program, Boston Children's Hospital, Boston; and Harvard Medical School, Boston, Massachusetts (K.L.R.).
- Computational Health Informatics Program, Boston Children's Hospital, Boston; and Departments of Pediatrics and Biomedical Informatics, Harvard Medical School, Boston, Massachusetts (K.D.M.).
ORCID-Profile: Kyra L Rosen, Kenneth D Mandl
Zitieren
APA
Rosen, K. L., & Mandl, K. D. (2026). What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence. Annals of Internal Medicine, 179(6), 895-897. https://doi.org/10.7326/annals-26-00362
Vancouver
Rosen KL, Mandl KD. What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence. Annals of Internal Medicine. 2026;179(6):895-897. doi:10.7326/annals-26-00362
BibTeX
@article{Rosen2026,
author = {Rosen, Kyra L and Mandl, Kenneth D},
title = {What FDA Clearance Does, and Does Not, Mean for Artificial Intelligence},
journal = {Annals of Internal Medicine},
year = {2026},
volume = {179},
number = {6},
pages = {895--897},
doi = {10.7326/annals-26-00362}
}
EUVIMED